New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
07:32 EDTALQAAlliqua to list on Nasdaq Capital Market on January 28
Alliqua has received approval from NASDAQ’s Listing Qualifications Department to list its common stock on the NASDAQ Capital Market. The Company anticipates that its common stock will commence trading on the NASDAQ Capital Market on January 28 under the same ticker symbol “ALQA”. Until that time, the Company’s common stock will continue to trade on the OTC Markets under the ticker symbol “ALQA”.
News For ALQA From The Last 14 Days
Check below for free stories on ALQA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
07:41 EDTALQAAlliqua to launch Biovance human amniotic membrane allograft product
Alliqua (ALQA) will launch its Biovance human amniotic membrane allograft product. Biovance was originally developed by, and is currently being manufactured through a supply agreement with, Celgene Cellular Therapeutics, a subsidiary of Celgene (CELG), to assist wound care specialists, physicians and nurses, as well as vascular, plastic and general surgeons, in the treatment of a wide variety of complex, acute, chronic, recalcitrant, full and partial thickness wound types. With the right to develop and market Biovance, Alliqua has entered into one of the fastest-growing areas of wound care, which involves regenerative medicine. Alliqua will commence sales of Biovance immediately following the Symposium via its team of direct sales representatives.
April 15, 2014
09:00 EDTALQAAlliqua falls 6.6%
Alliqua is down 6.6%, or 45c, to $6.34

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use